Additionally, daidzin suppresses PI3K/Akt/mTOR pathway and TGF-β expression, effectively impeding EMT and reducing invasiveness in colon (SNU-C2A) and prostate (DU145, PC-3) cancers (Wei et al., 2021). Here, AKT1 is linked to cancer.